Otsuka Holdings Co Ltd (4578.T) stock: key figures, P/E, revenue and dividend
Health Care · Japan · ISIN JP3188220002
Otsuka Holdings Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.33 tn JPY | 2.47 tn JPY |
| Gross profit | 1.67 tn JPY | 1.77 tn JPY |
| EBIT | 396.85 bn JPY | 423.77 bn JPY |
| Net income | 343.12 bn JPY | 363.15 bn JPY |
| Diluted EPS – continuing operations | 637.53 JPY | 688.94 JPY |
Full history since 2005, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Otsuka Holdings Co Ltd
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.
More stocks
- Legrand SA (LR.PA)
- Fomento Economico Mexicano (FMX)
- Consolidated Edison (ED)
- Swisscom AG (SCMN.SW)
- Yum! Brands (YUM)
- ORIX Corp (8591.T)
- Komatsu Ltd (6301.T)
- Strategy Inc (MSTR)
- JD.com Inc Adr (JD)
- Shaanxi Coal Industry Co Ltd (601225.SS)
- Asia Vital Components Co Ltd (3017.TW)
- Waste Connections, Inc. (WCN)
Not investment advice. All data without warranty, price as of 15.10.2026. Details in the risk notice.